The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
Rogue Funds declined 12.4% in Q1 2025 but manager Jacob Rowe expresses increased confidence in the portfolio heading into year three. The fund maintains a concentrated approach focused on catalyst-driven small-cap investments across uranium, biotechnology, data centers, and healthcare technology. Key holdings include ASP Isotopes, which has begun full production and expects significant revenue catalysts through Q4, and Global Atomic, benefiting from improved geopolitical conditions in Niger. The fund also holds Achieve Life Sciences, despite recent frustrations, with potential 5x-8x upside following upcoming clinical milestones. New positions include Biotricity, a healthcare technology company transitioning to an AI-focused SAAS model with pilot studies launching imminently. The portfolio has become more concentrated while removing all leverage due to expected macro volatility. Multiple catalysts are anticipated through August-September, with the manager expecting this could be the fund's best year despite continued high volatility from the concentrated positioning strategy.
Concentrated small-cap strategy focused on catalyst-driven investments in uranium, biotechnology, data centers, and healthcare technology with multiple near-term value inflection points expected over the next 6-9 months.
Manager expects third year of the Fund to possibly be the best year thus far with much more confidence in portfolio direction. Multiple catalysts expected through August/September timeframe with continuous stream of events through Q4. Volatility will continue but catalyst-driven strategy expected to separate returns from market despite being mainly long-only fund.
As of May 1, 2025
Jacob Rowe serves as Chief Investment Officer and founder of Rogue Funds, LLC, with seven years of experience in distressed securities and value investing. He holds Bachelor of Science degrees in Mechanical Engineering and Quantitative Economics from East Carolina University. Rowe began investing at age 13 and bought his first stock at age 14, expressing his desire to start a hedge fund since age 16. He recently joined ASP Isotopes as VP of Investor Relations while managing potential conflicts through institutional governance measures.
Rogue Funds adopts a bold and unconventional investment philosophy focusing on distressed securities and spinoffs. Their mission is to seek their unique path instead of conforming to the norm. The fund believes the key to success lies in taking a deep dive into each investment opportunity and understanding the underlying dynamics of the companies they invest in. They purchase assets below intrinsic value and hold them until value realization, focusing on companies undergoing significant changes that offer potential for high returns.
Lead Portfolio Manager
High Conviction Bullish
Market Conviction
Very high conviction evidenced by increased concentration, detailed catalyst timelines, specific price targets (5x-8x, 10x-20x), and manager's explicit statement of increased confidence in portfolio direction going forward.
Growth Outlook
Manager expresses cautious optimism about macro environment, acknowledging expected volatility for first nine months but showing confidence in catalyst-driven opportunities. Mixed signals with economic contraction concerns balanced by sector-specific opportunities.
Risk Appetite
Portfolio became more concentrated toward highest conviction positions while completely removing leverage, indicating selective risk-taking. Manager maintains aggressive positioning in small-cap names but shows defensive awareness by deleveraging.
Capital Deployment
Moderate deployment activity with fund becoming more concentrated in existing positions while removing two positions. No mention of significant cash level changes, suggesting selective rebalancing rather than aggressive new deployment.
Forward Guidance
Strong bullish bias with manager expecting third year to possibly be the best yet. Multiple catalysts anticipated through Q4 with continuous stream of positive events expected for core holdings.
Language Signal
Language shows net positive bias with terms like 'sky's the limit', 'extreme upwards pressure', and 'insane heights' for opportunities, balanced by acknowledgment of frustrations and volatility challenges.
Perceived Risk
Moderate to high risk perception with explicit acknowledgment of expected macro volatility for nine months, economic contraction concerns, and tariff impacts. Manager removed leverage specifically due to risk concerns.
Opportunity Density
High opportunity density within specific sectors, particularly uranium and healthcare technology. Manager identifies multiple catalyst-rich opportunities with clear timelines and significant upside potential across core holdings.
Time Horizon
Medium to long-term orientation with catalyst timelines extending through Q4 2025 and 18-24 month return expectations for some positions. Manager emphasizes long-term investor orientation while focusing on near-term catalysts.
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Rogue Funds, LLC or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.
